F
Franco Borzio
Researcher at University of Milan
Publications - 68
Citations - 4744
Franco Borzio is an academic researcher from University of Milan. The author has contributed to research in topics: Hepatocellular carcinoma & Liver cancer. The author has an hindex of 36, co-authored 68 publications receiving 4084 citations.
Papers
More filters
Journal ArticleDOI
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice
Edoardo G. Giannini,Laura Bucci,Francesca Garuti,Matteo Brunacci,Barbara Lenzi,Matteo Valente,Eugenio Caturelli,Giuseppe Cabibbo,Fabio Piscaglia,Roberto Virdone,Martina Felder,Francesca Ciccarese,Francesco Giuseppe Foschi,Rodolfo Sacco,Gianluca Svegliati Baroni,Fabio Farinati,Gian Lodovico Rapaccini,Andrea Olivani,Antonio Gasbarrini,Maria Di Marco,Filomena Morisco,Marco Zoli,Alberto Masotto,Franco Borzio,Luisa Benvegnù,Fabio Marra,Antonio Colecchia,Gerardo Nardone,Mauro Bernardi,Franco Trevisani +29 more
TL;DR: BCLC C stage does not identify patients homogeneous enough to be allocated to a single stage, and new patient‐tailored therapeutic indications are needed.
Journal ArticleDOI
Contrast-enhanced doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis
Anna Ludovica Fracanzani,L. Burdick,Mauro Borzio,Massimo Roncalli,Nicola Bonelli,Franco Borzio,A. Maraschi,Gemino Fiorelli,Silvia Fargion +8 more
TL;DR: Contrast‐enhanced Doppler US is a noninvasive, very sensitive technique in differentiating malignant and premalignant lesions from nonmalignant focal lesions in the liver.
Journal ArticleDOI
The changing scenario of hepatocellular carcinoma over the last two decades in Italy.
V. Santi,Daniela Buccione,Antonio Di Micoli,G. Fatti,Marta Frigerio,Fabio Farinati,Paolo Poggio,Gianludovico Rapaccini,Maria Anna Di Nolfo,Luisa Benvegnù,Marco Zoli,Franco Borzio,Edoardo G. Giannini,Eugenio Caturelli,Maria Chiaramonte,Mauro Bernardi,Franco Trevisani +16 more
TL;DR: The survival improvement observed until 2001 was due to an increasing number of tumours diagnosed in early stages and in a background of compensated cirrhosis, and a growing and better use of locoregional treatments, and national policies aimed at implementing surveillance programmes for at risk patients.
Journal ArticleDOI
Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma.
Maria Chiara Cantarini,Franco Trevisani,Antonio Maria Morselli-Labate,Gianludovico Rapaccini,Fabio Farinati,Paolo Poggio,Maria Anna Di Nolfo,Luisa Benvegnù,Marco Zoli,Franco Borzio,Mauro Bernardi +10 more
TL;DR: Hepatitis B virus-related hepatocellular carcinomas have a greater aggressiveness than hepatitis C virus- related tumors, which becomes clinically manifest once they have reached an advanced stage.
Journal ArticleDOI
Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center study
Fabio Farinati,A. Sergio,Anna Baldan,A. Giacomin,Maria Anna Di Nolfo,Paolo Poggio,Luisa Benvegnù,Gianludovico Rapaccini,Marco Zoli,Franco Borzio,Edoardo G. Giannini,Eugenio Caturelli,Franco Trevisani +12 more
TL;DR: Patients with very early" HCC were very few in this analysis and in most instances they were not treated with the treatment suggested as the most appropriate by the AASLD guidelines and the type of treatment had no impact on survival, even though the number of patients was relatively low.